D
David Cohen
Researcher at Pierre-and-Marie-Curie University
Publications - 787
Citations - 45536
David Cohen is an academic researcher from Pierre-and-Marie-Curie University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 83, co-authored 635 publications receiving 37722 citations. Previous affiliations of David Cohen include University of California, Berkeley & University of Michigan.
Papers
More filters
Journal ArticleDOI
Principes de surveillance des effets métaboliques, de l’hyperprolactinémie et du rythme cardiaque pour les antipsychotiques atypiques chez l’enfant et l’adolescent
TL;DR: Le syndrome metabolique est le plus connu des risques mais justifie une surveillance precise and fait l’objet de recommandations internationales, enfin nous evoquons the question du risque cardiaque.
Journal ArticleDOI
Relationships Between Self-Injurious Behaviors, Pain Reactivity, and β-Endorphin in Children and Adolescents With Autism.
Sylvie Tordjman,George M. Anderson,Annaëlle Charrier,Cécile Oriol,Solenn Kermarrec,Solenn Kermarrec,Roberto Canitano,Michel Botbol,Nathalie Coulon,Corinne Antoine,Sylvie Brailly-Tabard,David Cohen,Hazar Haidar,Séverine Trabado,Michèle Carlier,Guillaume Bronsard,Laurent Mottron +16 more
TL;DR: The absence of any observed relationships between β-endorphin level and SIB or pain reactivity and the conflicting results of prior opioid studies in autism tend to undermine support for the opioid theory of autism.
Journal ArticleDOI
Cost-effectiveness of oral antiplatelet agents--current and future perspectives.
TL;DR: The results of published evaluations of the cost-effectiveness of oral antiplatelet strategies for use across a range of clinical conditions and treatment settings are reviewed and support the use of aspirin for primary prevention in high-risk patients and for secondary prevention in all patients with previous cardiovascular events.
Journal ArticleDOI
Impact of Local Anesthesia Only Versus Procedural Sedation Using the Vancouver Clinical Pathway for TAVR: Insights From the 3M TAVR Study.
Janarthanan Sathananthan,John G. Webb,Sandra Lauck,John A. Cairns,Karin H. Humphries,Tamim Nazif,Vinod H. Thourani,David Cohen,Martin B. Leon,David A. Wood,M Tavr Investigators +10 more
TL;DR: In patients undergoing transcatheter aortic valve replacement (TAVR), a “minimalist” approach has been advocated with a focus on simplification of both procedural steps and patient care.
Journal ArticleDOI
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
André L. Queiroz,Ezequiel Dantas,Shakti Ramsamooj,Anirudh Murthy,Mujmmail Ahmed,Elizabeth R M Zunica,Roger Liang,Jessica Murphy,Corey D. Holman,Curtis J. Bare,Gregory C. Ghahramani,Zhidan Wu,David Cohen,John P. Kirwan,Lewis C. Cantley,Christopher L. Axelrod,Marcus D. Goncalves +16 more
TL;DR: In this article , the authors identify Activin A as a purported driver of cachexia and treat with ActRIIB-Fc, a decoy ligand for TGF-β/activin family members, together with anamorelin (Ana), a ghrelin receptor agonist, to reverse muscle dysfunction and anorexia, respectively.